ID: MRFR/Pharma/1127-HCR | February 2021 | Region: Global | 85 pages
The rheumatoid arthritis market is expected to grow at the rate of about XX% CAGR from 2020 to 2027. Globally the market for rheumatoid arthritis is increasing rapidly. The major factor that derives the growth of rheumatoid arthritis is the increasing aging population. Furthermore, some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis.
Key Players for Rheumatoid Arthritis Market:
Some of the key players in this market are: Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) and many others.
Rheumatoid Arthritis Market Segments:
rheumatoid arthritis market has been segmented on the basis of drug type which comprises of Non-steroidal anti-inflammatory drug type (NSAID), Steroids, and Disease-modifying anti-rheumatic drug type (DMARDs) and Biologic agents. On the basis of treatment include Synovectomy, Tendon repair, Joint fusion and Total joint replacement. Furthermore, on the basis of diagnosis includes C - reactive protein (CRP) Test, CCP, ESR (Erythrocyte Sedimentation Rate) Test and Synovial Fluid Analysis.
Regional Analysis of Rheumatoid arthritis Market:
Globally North America is the largest market for rheumatoid arthritis. The North American market for rheumatoid arthritis is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Europe is the second-largest market for rheumatoid arthritis which is expected to grow at a CAGR of XX%. Furthermore, Asia pacific market is expected to be the fastest growing market for rheumatoid arthritis.
The report for Global Rheumatoid Arthritis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
Study Objectives of Rheumatoid arthritis Market:
|Market Size||2027: Significant Value|
|CAGR||2020-2027: Substantial CAGR|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||drug type, diagnosis and treatment|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K)|
|Key Market Opportunities||Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments|
|Key Market Drivers||Increasing aging population|
Frequently Asked Questions (FAQ) :
global rheumatoid arthritis market is estimated to grow at approximately 4% CAGR during the review period (2017-2022).
Huge investments for the development of products related to rheumatoid arthritis treatment and rise in the global economy that is widening the access to the quality care are the major tailwinds pushing the growth of the global rheumatoid arthritis market.
North America holds the largest share in the global rheumatoid arthritis market, followed by Europe and the Asia Pacific, respectively.
Eli Lilly and company (US), Pfizer Inc. (US), Bristol-Myers Squibb Company (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Incorporated (US), AstraZeneca (UK), and Sanofi (France), are some of the major players operating in the rheumatoid arthritis market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global rheumatoid arthritis market adopt to gain a larger competitive advantage.